Syncom Formulation (India) Share Price
₹17.91 -0.48 (-2.61%)
22 Jan, 2025 12:35
Start SIP in SYNCOMF
Start SIPPerformance
- Low
- ₹18
- High
- ₹18
- 52 Week Low
- ₹11
- 52 Week High
- ₹28
- Open Price₹18
- Previous Close₹18
- Volume904,683
Investment Returns
- Over 1 Month -12.25%
- Over 3 Month -10.23%
- Over 6 Month + 17.14%
- Over 1 Year + 12.85%
Smart Investing Starts Here Start SIP with Syncom Formulation (India) for Steady Growth!
Syncom Formulation (India) Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 50.8
- PEG Ratio
- 1.2
- Market Cap Cr
- 1,684
- P/B Ratio
- 5.4
- Average True Range
- 0.82
- EPS
- 0.35
- Dividend Yield
- 0
- MACD Signal
- -0.62
- RSI
- 40.97
- MFI
- 36.35
Syncom Formulation (India) Financials
Syncom Formulation (India) Technicals
EMA & SMA
Current Price
₹17.91
-0.48
(-2.61%)
- Bearish Moving Average 0
- Bullish Moving Average 0
- 20 Day
- ₹19.18
- 50 Day
- ₹19.90
- 100 Day
- ₹19.63
- 200 Day
- ₹18.00
Resistance and Support
18.53
- R3 19.71
- R2 19.36
- R1 18.88
- S1 18.05
- S2 17.70
- S3 17.22
Syncom Formulation (India) Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-11-11 | Quarterly Results | |
2024-08-12 | Quarterly Results | |
2024-05-17 | Audited Results | |
2024-02-14 | Quarterly Results | |
2023-11-08 | Quarterly Results |
Syncom Formulation (India) F&O
About Syncom Formulation (India)
- NSE Symbol
- SYNCOMF
- BSE Symbol
- 524470
- Managing Director
- Mr. Vijay Shankarlal Bankda
- ISIN
- INE312C01025
Similar Stocks to Syncom Formulation (India)
Syncom Formulation (India) FAQs
Syncom Formulation (India) share price is ₹17 As on 22 January, 2025 | 12:21
The Market Cap of Syncom Formulation (India) is ₹1683.5 Cr As on 22 January, 2025 | 12:21
The P/E ratio of Syncom Formulation (India) is 50.8 As on 22 January, 2025 | 12:21
The PB ratio of Syncom Formulation (India) is 5.4 As on 22 January, 2025 | 12:21
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.